/ /

  • linkedin
  • Increase Font
  • Sharebar

    5 Stubborn Statin Myths vs Data that Refute Them

     

    The data: Collins R, Reith C, Emberson J, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016; 388: 2532–61.http://dx.doi.org/10.1016/

    Seth Martin, MD
    Dr. Martin is an assistant professor at the Ciccarone Center for the Prevention of Heart Disease at the Johns Hopkins University School ...

    1 Comment

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • UBM User
      I don't find this convincing. The two big issues are myalgias and diabetes risk. Among my patients, myalgias are by far the most common SE. The data shown are for myonecrosis, which is not required for myalgias to occur. The data for diabetes actually support an increased risk for diabetes, and just explain that it's already factored in to treatment decisions. Not good enough.